Skip to main content
2024 ACRM Annual Fall Conference & EXPO Main banner
G4 Foot Drop System
REGISTER NOW
REGISTER NOW
Final Program


AT-A-GLANCE PDF
Back

Constantinos Deltas

Director, biobank.cy Center of Excellence in Biobanking and Biomedical Research
School of Medicine, University of Cyprus
Nicosia, Nicosia, Cyprus

Prof. C. Deltas studied Pharmacy at the National Kapodistrian University of Athens. He received his PhD in Biochemistry at Rutgers Univ., NJ, USA, January 1988. While working at Duke University School of Medicine in 1991, he was invited to join the newly established Cyprus Institute of Neurology and Genetics, where he started the first molecular genetics laboratory on hereditary kidney diseases and other disorders. In 2002 he was elected Professor of Genetics at the newly established Dept of Biological Sciences, University of Cyprus, serving as first Chairperson, contributing to the preparation of curricula and the research laboratories. Since 2020 he is Professor of Medical and Molecular Genetics at the Medical School, Univ. of Cyprus.
With funding from the European Union, the Republic of Cyprus and the Univ. of Cyprus, he is Founder and Director of the biobank.cy Centre of Excellence in Biobanking and Biomedical Research, including the first Biobank in the country. He is leading the Cyprus Human Genome Project, which recently completed the first phase of the CYPROME, based on 1000 Cypriot whole exomes.
He developed a diagnostics laboratory to offer molecular testing for inherited kidney conditions acting as a referral center since 1991, and systematic genetic testing for inherited cardiomyopathies and arrhythmias, amongst others.
He published >150 papers and presented his work in international conferences and Universities. He is a member of the International Workshop Organizing Committee for Alport Syndrome Alliance, and a member of the Regional Council of Central and Eastern Europe of the International Society of Nephrology. His research had instrumental contribution in cloning of the PKD2 gene, the two-hit hypothesis for cyst formation in polycystic kidney disease, while he published first landmark paper associating convincingly the collagen IV mutations that cause Alport syndrome and thin basement membrane nephropathy with focal segmental glomerulosclerosis.

Disclosure information not submitted.

Presentation(s):